Curative Biotechnology Inc (CUBT)

[dunwifit]

$CTYX here are some comparisons to other orphan drug companies:

"Amgen and Biogen are expected to turn to M&As in the near future as a means to maintain their presence in the orphan drugs sector”
~ Maura Musciacco, GlobalData

Amgen: AMGN (NASDAQ) $258.46
Biogen: BIIB (NASDAQ) $281.88

$CTYX is just getting started, but check out this comparison to see where it might be heading:

Connectyx Technologies Holdings Group, Inc.
$CTYX (OTC) $0.009
OS 322,800,327
Float only 188,707,258

Alexion Pharmaceuticals, Inc.
$ALXN (NASDAQ) $109.24
OS 220,827,431

$CTYX here is a more down-to-earth comparison:

Connectyx Technologies Holdings Group, Inc.
$CTYX (OTC) $0.009
Market Cap $2,905,203

Akcea Therapeutics, Inc.
$AKCA (NASDAQ) $12.87
Market Cap $1,306,423,700

$CTYX and just so you know, Akcea Therapeutics only has 2 approved drugs with six more in the pipeline, while Connectyx Technologies Holdings Group is working on their first. This is the ground floor, but watch how quickly they grow!